Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gingivitis and Systemic Biomarkers
NCT06962956Phase 1Active, not recruiting
- Sponsor
- Procter & Gamble
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of stannous fluoride in gingivitis (3 arms), sponsored by Procter & Gamble. Primary endpoint: Number Bleeding Sites at 4 months. Started Apr 2025; status: active, not recruiting.
02
Drugs
stannous fluoride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT06962956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06962956.